Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study
eLife · 2023
DOI: 10.7554/elife.81605 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Mette Hartmann Nonboe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Epidemiological Research, Nykøbing Falster Hospital, Nykøbing Falster, Denmark. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, COVID-19, Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Zealand.
Abstract (Originalsprache)
Background
Denmark was one of the few countries where it was politically decided to continue cancer screening during the COVID-19 pandemic. We assessed the actual population uptake of mammography and cervical screening during this period.
Methods
The first COVID-19 lockdown in Denmark was announced on 11 March 2020. To investigate possible changes in cancer screening activity due to the COVID-19 pandemic, we analysed data from the beginning of 2017 until the end of 2021. A time series analysis was carried out to discover possible trends and outliers in the screening activities in the period 2017–2021. Data on mammography screening and cervical screening were retrieved from governmental pandemic-specific monitoring of health care activities.
Results
A brief drop was seen in screening activity right after the first COVID-19 lockdown, but the activity quickly returned to its previous level. A short-term deficit of 43% [CI –49 to –37] was found for mammography screening. A short-term deficit of 62% [CI –65 to –58] was found for cervical screening. Furthermore, a slight, statistically significant downward trend in cervical screening from 2018 to 2021 was probably unrelated to the pandemic. Other changes, for example, a marked drop in mammography screening towards the end of 2021, also seem unrelated to the pandemic.
Conclusions
Denmark continued cancer screening during the pandemic, but following the first lockdown a temporary drop was seen in breast and cervical screening activity. Funding: Region Zealand (R22-A597).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Epidemiological Research, Nykøbing Falster Hospital, Nykøbing Falster, Denmark.
- Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
- Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark.
- Department of Breast Examinations, Copenhagen University Hospital Herlev/Gentofte, Copenhagen, Denmark.
- Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark.
ORCID-Profile: Mette Hartmann Nonboe
Förderung
- Region Zealand
Zitieren
APA
Nonboe, M. H., Napolitano, G., Schroll, J. B., Vejborg, I., Waldstrøm, M., & Lynge, E. (2023). Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study. eLife. https://doi.org/10.7554/elife.81605
Vancouver
Nonboe MH, Napolitano G, Schroll JB, Vejborg I, Waldstrøm M, Lynge E. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study. eLife. 2023. doi:10.7554/elife.81605
BibTeX
@article{Nonboe2023,
author = {Nonboe, Mette Hartmann and Napolitano, George and Schroll, Jeppe Bennekou and Vejborg, Ilse and Waldstrøm, Marianne and Lynge, Elsebeth},
title = {Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.81605}
}
EUVIMED